Multiple Sclerosis

Home/Disease Specific/Multiple Sclerosis

National Multiple Sclerosis Society Commits to $17 Million for 43 Research Projects

The National Multiple Sclerosis Society is pumping $17 million into 43 research projects that represent almost half of its $40-million research funding commitment in 2017. Among the projects are trials evaluating intermittent fasting as a way to harness inflammation and stem cell research. A growing number of studies indicate that stem cells can slow MS activity and repair the damage

Stem cell transplants may induce long-term remission of multiple sclerosis

Wednesday, February 1, 2017 Encouraging results help set stage for larger studies. New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system. “...these

Breakthrough Stem Cell Treatment Could ‘Halt’ Multiple Sclerosis

September 19, 2016 Scientists in Canada have developed a radical treatment that can potentially ‘halt’multiple sclerosis in its tracks. The breakthrough treatment involves effectively destroying a person’s immune system and then building it back up using stem cells. While risky, the process could even reverse the symptoms of aggressive MS. The scientists have warned however

MS breakthrough: Replacing diseased immune system halts progression and allows repair

June 9, 2016 Clinical trial suggests chemo and blood stem cell combination therapy should be considered for people with early, aggressive MS A clinical trial published in The Lancet, a top medical journal, shows that an intensive procedure that completely wipes out the immune system and then regenerates a new one using blood stem cells can

Exercise May Impact Reduced Disease Activity in Children with MS

Thu, 08/13/2015 - 8:33am Bevin Fletcher, Associate Editor Children with multiple sclerosis (MS) who get regular exercise may have a less active disease, according to a new study published online Wednesday in the journal Neurology. Children responded to questionnaires about tiredness, depression and exercise habits.  The study included 79 children who had experienced a single

Major step for implantable drug-delivery device

MIT spinout signs deal to commercialize microchips that release therapeutics inside the body. Rob Matheson | MIT News Office June 29, 2015 An implantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases: Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly

New technology looks into the eye and brings cells into focus

Photo by L. Brian Stauffer Dr. Stephen Boppart led a team that developed a new medical imaging device that can see individual cells in the back of the eye to better diagnose and track disease. From left: postdoctoral researcher Yuan-Zhi Liu, graduate student Fredrick A. South, and professor Stephen Boppart. 6/22/2015 | Liz Ahlberg, Physical

Stem cells as the road to repairing Multiple Sclerosis

A clinical trial set to begin this month in Ottawa will test the safety and efficacy of mesenchymal stem cells to stimulate repair of damaged nerves in MS patients. This article was published simultaneously on Signals Blog. June3, 2015 By Lisa Willemse On any given day at the general campus of The Ottawa Hospital, you’re

Regenerative Medicine Study Underscores Lung Regeneration Capacity

April 28, 2015, Reid D'Amoco In diseases like cystic fibrosis, the lungs undergo constant healing and remodeling due to chronic infections. To better understand the repair mechanisms the lungs go through in diseases like CF and COPD, scientists have paid great attention to studying cellular regeneration. Scientists at the University of Pennsylvania and Duke University have discovered

Gladstone Scientists Discover Potential New Treatment for Multiple Sclerosis

Finding could have implications for other autoimmune disorders, such as type I diabetes SAN FRANCISCO, CA—APRIL 27, 2015—Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation and autoimmunity, the